Friday, 08 July 2022 18:52

Anticoagulation news items. Week commencing 4th July 2022

Anticoagulants for thrombosis prophylaxis in acutely ill patients admitted to hospital: systematic review and network meta-analysis

British Medical Journal
Review (44 RCTs;n=90 ,095) concluded overall, intermediate dose low-molecular-weight heparin was most likely to reduce symptomatic venous thromboembolism and intermediate dose unfractionated heparin and direct oral anticoagulants most likely to increase risk of major bleeding.

 

 

The above records have been identified by UKMi and feature in the NICE Medicines Awareness Service. Further details on this service can be found at:

http://www.evidence.nhs.uk/about-evidence-services/content-and-sources/medicines-information/new-medicines-awareness-services